A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease
Clinical trial NCT04220632 · TERMINATED
Trial details
- NCT number
- NCT04220632
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-18
- Primary completion
- 2020-10-10
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.